Harmony Biosciences Holdings Inc logo

Harmony Biosciences Holdings Inc

HRMY
Healthcare|Biotechnology|USA
$36.87
-1.38 (-3.61%)
DCF (FCF)
$50.96
Tangible Book
$14.29
Graham Number
$29.30
Earnings Power
$41.99

Upcoming Data Readouts (6)

Nov 2026
Est. completion
P3Lennox Gastaut Syndrome
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
NCT05066217n=260
Apr 2027
Est. completion
P3Dravet Syndrome
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
NCT04462770n=150
Apr 2027
Est. completion
NAChild Abuse
ACT-Based Training for Parental Burnout and Child Well-being
NCT07047378n=120
Oct 2027
Est. completion
P3EDS
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
NCT07675135n=258
Oct 2027
Est. completion
P3Idiopathic Hypersomnia
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
NCT07500090n=248
Jun 2030
Est. completion
Pregnancy Related
WAKIX® (Pitolisant) Pregnancy Registry
NCT05536011n=1,329

Awaiting Results (4)

Trials past primary completion date but still active — data readout may be imminent.

May 2026
NA
Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning Hair
NCT07520019
Oct 2025
NA
You, Me and Nature Pilot Study
NCT06451978
Jun 2025
NA
Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being
NCT06014281
Jul 2024
NA
The UPbeating GReek Application of DancE in Parkinson's Disease Clinical Trial
NCT06220084

Recent Press Releases